Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine
| Status: | Completed |
|---|---|
| Conditions: | Ovarian Cancer, Cancer, Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 12/30/2017 |
| Start Date: | May 2005 |
| End Date: | January 2010 |
RATIONALE: Chemotherapy, such as paclitaxel and carboplatin, work in different ways to stop
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Hypnosis, massage therapy, and healing touch may improve the quality of life of patients who
are undergoing chemotherapy.
PURPOSE: This randomized clinical trial is studying how well giving hypnosis, massage therapy
and healing touch changes outcomes in women receiving chemotherapy for newly diagnosed
epithelial ovarian, fallopian tube or peritoneal cavity cancer.
the growth of tumor cells, either by killing the cells or by stopping them from dividing.
Hypnosis, massage therapy, and healing touch may improve the quality of life of patients who
are undergoing chemotherapy.
PURPOSE: This randomized clinical trial is studying how well giving hypnosis, massage therapy
and healing touch changes outcomes in women receiving chemotherapy for newly diagnosed
epithelial ovarian, fallopian tube or peritoneal cavity cancer.
OBJECTIVES:
Primary
- Determine whether quality of life is improved in patients with epithelial ovarian,
fallopian tube or primary peritoneal cavity cancer receiving hypnosis, massage therapy,
and healing touch and standard chemotherapy as compared to patients receiving standard
chemotherapy alone.
Secondary
- Determine changes in immunologic response markers, chemotherapy side effects, and
complication rates in these patients.
OUTLINE: This is a randomized study. Patients are randomized to 1 of 2 treatment arms.
- Arm I (standard therapy): Patients undergo standard chemotherapy for epithelial ovarian,
fallopian tube or primary peritoneal cancer.
- Arm II (standard therapy with complementary alternative medicine): Patients undergo
chemotherapy as in arm I. Patients also undergo massage over approximately 30 minutes
and healing touch therapy over approximately 30 minutes with each course of chemotherapy
1-6 and hypnosis over 30-60 minutes during courses 1, 2, and 4.
Quality of life is assessed at baseline, during courses 3 and 6 of chemotherapy, and then 6
months after completion of study treatment.
After completion of study treatment, patients are followed at 6 months.
Primary
- Determine whether quality of life is improved in patients with epithelial ovarian,
fallopian tube or primary peritoneal cavity cancer receiving hypnosis, massage therapy,
and healing touch and standard chemotherapy as compared to patients receiving standard
chemotherapy alone.
Secondary
- Determine changes in immunologic response markers, chemotherapy side effects, and
complication rates in these patients.
OUTLINE: This is a randomized study. Patients are randomized to 1 of 2 treatment arms.
- Arm I (standard therapy): Patients undergo standard chemotherapy for epithelial ovarian,
fallopian tube or primary peritoneal cancer.
- Arm II (standard therapy with complementary alternative medicine): Patients undergo
chemotherapy as in arm I. Patients also undergo massage over approximately 30 minutes
and healing touch therapy over approximately 30 minutes with each course of chemotherapy
1-6 and hypnosis over 30-60 minutes during courses 1, 2, and 4.
Quality of life is assessed at baseline, during courses 3 and 6 of chemotherapy, and then 6
months after completion of study treatment.
After completion of study treatment, patients are followed at 6 months.
Inclusion Criteria:
- Newly diagnosed epithelial ovarian, primary peritoneal or fallopian tube cancer, any
pathologic type or stage, who will receive 6 cycles of chemotherapy.
- Patients must have signed an informed consent
Exclusion Criteria:
- Previous cancer other than skin cancer
- Previous chemotherapy experience
- Active substance abuse
- Schizophrenia
- Pregnant or lactating
We found this trial at
1
site
425 E River Pkwy # 754
Minneapolis, Minnesota 55455
Minneapolis, Minnesota 55455
612-624-2620
Masonic Cancer Center at University of Minnesota The Masonic Cancer Center was founded in 1991....
Click here to add this to my saved trials
